Volume 10, Issue 3, Pages (September 2009)

Slides:



Advertisements
Similar presentations
Lukasova M. et al. J Clin Invest 2011;121:
Advertisements

Macrophage ABCA2 deletion modulates intracellular cholesterol deposition, affects macrophage apoptosis, and decreases early atherosclerosis in LDL receptor.
Anti-oxidant and anti-atherogenic properties of liposomal glutathione: Studies in vitro, and in the atherosclerotic apolipoprotein E-deficient mice  Rosenblat.
Arterioscler Thromb Vasc Biol
MicroRNA-27a/b regulates cellular cholesterol efflux, influx and esterification/hydrolysis in THP-1 macrophages  Min Zhang, Jian-Feng Wu, Wu-Jun Chen,
Omega-6 polyunsaturated fatty acids prevent atherosclerosis development in LDLr-KO mice, in spite of displaying a pro-inflammatory profile similar to.
Paul Durrington  Atherosclerosis Supplements 
Arterioscler Thromb Vasc Biol
Adipose Tissue ATP Binding Cassette Transporter A1 Contributes to High-Density Lipoprotein Biogenesis In VivoClinical Perspective by Soonkyu Chung, Janet.
Volume 45, Issue 6, Pages (December 2016)
Volume 20, Issue 1, Pages (July 2014)
Volume 13, Issue 4, Pages (April 2011)
Volume 16, Issue 1, Pages (July 2012)
Wip1-Dependent Regulation of Autophagy, Obesity, and Atherosclerosis
Volume 15, Issue 1, Pages (January 2012)
Volume 4, Issue 3, Pages (September 2006)
Volume 15, Issue 4, Pages (April 2012)
Sebelipase alfa improves atherogenic biomarkers in adults and children with lysosomal acid lipase deficiency  Don P. Wilson, MD, FNLA, Mark Friedman,
Volume 8, Issue 5, Pages (November 2008)
Volume 12, Issue 2, Pages (August 2010)
Volume 10, Issue 11, Pages (March 2015)
Volume 56, Issue 1, Pages (October 2007)
Volume 11, Issue 3, Pages (March 2010)
A Macrophage Sterol-Responsive Network Linked to Atherogenesis
Volume 20, Issue 5, Pages (November 2014)
Dysregulation of LDL receptor under the influence of inflammatory cytokines: A new pathway for foam cell formation1  Dr Xiong Z. Ruan, Zac Varghese, Stephen.
Volume 15, Issue 6, Pages (June 2012)
Volume 141, Issue 4, Pages e5 (October 2011)
Volume 15, Issue 3, Pages (March 2012)
Volume 12, Issue 4, Pages (October 2010)
Volume 14, Issue 6, Pages (December 2011)
New Therapeutic Approaches to the Treatment of Dyslipidemia
Guido T. Bommer, Ormond A. MacDougald  Cell Metabolism 
Volume 12, Issue 2, Pages (August 2010)
Volume 21, Issue 16, Pages (August 2011)
Autophagy Links Inflammasomes to Atherosclerotic Progression
Volume 12, Issue 3, Pages (September 2010)
Volume 13, Issue 8, Pages (November 2015)
Volume 6, Issue 6, Pages (December 2007)
Volume 18, Issue 13, Pages (March 2017)
Volume 14, Issue 10, Pages (March 2016)
Volume 8, Issue 6, Pages (December 2008)
Volume 45, Issue 6, Pages (December 2016)
Daniel J. Rader, Ellen Puré  Cell Metabolism 
Volume 7, Issue 2, Pages (February 2008)
Volume 7, Issue 1, Pages (January 2001)
Volume 2, Issue 3, Pages (September 2000)
Volume 1, Issue 2, Pages (February 2005)
Volume 9, Issue 5, Pages (May 2009)
Volume 3, Issue 4, Pages (April 2006)
Volume 10, Issue 1, Pages (July 2009)
Volume 8, Issue 4, Pages (October 2008)
Volume 8, Issue 6, Pages (December 2008)
Volume 10, Issue 5, Pages (November 2009)
Volume 19, Issue 2, Pages (February 2014)
Volume 15, Issue 3, Pages (March 2012)
Volume 8, Issue 6, Pages (December 2008)
Volume 18, Issue 2, Pages (August 2013)
Volume 10, Issue 6, Pages (December 2009)
Daniel J. Rader, Ellen Puré  Cell Metabolism 
High-Fat Diet Triggers Inflammation-Induced Cleavage of SIRT1 in Adipose Tissue To Promote Metabolic Dysfunction  Angeliki Chalkiadaki, Leonard Guarente 
Volume 4, Issue 5, Pages (November 2006)
Volume 23, Issue 1, Pages (January 2016)
Xiaoyue Pan, Yuxia Zhang, Li Wang, M. Mahmood Hussain  Cell Metabolism 
Volume 16, Issue 4, Pages (October 2012)
Volume 27, Issue 4, Pages e4 (April 2018)
Absence of miR‐21 in macrophages promotes foam cell formation
Volume 1, Issue 3, Pages (March 2005)
Volume 21, Issue 16, Pages (August 2011)
Volume 1, Issue 5, Pages (May 2005)
Presentation transcript:

Volume 10, Issue 3, Pages 219-228 (September 2009) Ablation of Neutral Cholesterol Ester Hydrolase 1 Accelerates Atherosclerosis  Motohiro Sekiya, Jun-ichi Osuga, Shuichi Nagashima, Taichi Ohshiro, Masaki Igarashi, Hiroaki Okazaki, Manabu Takahashi, Fumiko Tazoe, Taeko Wada, Keisuke Ohta, Mikio Takanashi, Masayoshi Kumagai, Makiko Nishi, Satoru Takase, Naoya Yahagi, Hiroaki Yagyu, Ken Ohashi, Ryozo Nagai, Takashi Kadowaki, Yusuke Furukawa, Shun Ishibashi  Cell Metabolism  Volume 10, Issue 3, Pages 219-228 (September 2009) DOI: 10.1016/j.cmet.2009.08.004 Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 1 nCEH Activity and Cholesterol Trafficking in Nceh1−/− Macrophages (A) Peritoneal macrophages (n = 7–8) were incubated with DMEM containing 10% FCS. Neutral cholesterol ester hydrolase (nCEH) activity or triglyceride lipase (TGL) activity of whole-cell lysates were measured. (B) The nCEH activity after subcellular fractionation (n = 8). (C)Intracellular levels of cholesterol ester (CE) or free cholesterol (FC) in macrophages. Peritoneal macrophages (n = 7–8) were incubated with increasing concentrations of acLDL for 24 hr (symbol definitions given in the inset, n = 7–8). (D) CE formation. Peritoneal macrophages (n = 7) were incubated with acLDL and [1-14C]oleate-albumin complex for 24 hr, and the incorporation of [1-14C]oleate into CE fraction was measured. (E) Cholesterol efflux. After labeling of cells (n = 5) with radiolabeled acLDL, the medium was changed to DMEM/FCS containing acLDL with or without HDL3. After 24 hr, the radioactivity of an aliquot of the medium and of the cell lysate was measured. The percent efflux was calculated as (media dpm)/(cell + media dpm) × 100. (F) Microsomal ACAT activity (n = 8). ACAT activity in microsomes was determined by the rate of incorporation of [1-14C]oleoyl-CoA into the CE fraction. Data are expressed as the mean ± SEM. ∗ and ∗∗ denote p < 0.05 and p < 0.01, respectively, as determined by ANOVA followed by the Tukey-Kramer posthoc test. Cell Metabolism 2009 10, 219-228DOI: (10.1016/j.cmet.2009.08.004) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 2 Foam Cell formation Induced by beta-VLDL or Oxidized LDL (A) Peritoneal macrophages (n = 5–6 for each genotype) were incubated with beta-VLDL (10 or 20 μg/ml) for 24 hr, and intracellular CE content and FC content were determined. As a control, the same cells were also incubated with acLDL (100 μg/ml) simultaneously. (B) Peritoneal macrophages (n = 7 for each genotype) were incubated with oxLDL (50 μg/ml) or acLDL (50 μg/ml) for 24 hr, and intracellular CE content and FC content were determined. (C and D) CE formation. Peritoneal macrophages (n = 6–7 for each genotype) were incubated with beta-VLDL (10 or 20 μg/ml, C) or oxidized LDL (oxLDL) (50 μg/ml, D) in the presence of [1-14C]oleate-albumin complex for 24 hr. Intracellular lipids were separated by thin layer chromatograpy (TLC), spots corresponding to the CE fraction were scraped off, and radioactivity was measured. As a control, the same cells were incubated with acLDL. Data are expressed as the mean ± SEM. ∗ and ∗∗ denote p < 0.05 and p < 0.01, respectively, as determined by ANOVA followed by the Tukey-Kramer posthoc test. Cell Metabolism 2009 10, 219-228DOI: (10.1016/j.cmet.2009.08.004) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 3 Atherosclerosis in Nceh1−/−;Apoe−/− Mice (A) Nceh1-deficient mice were crossed with Apoe-deficient mice, and fed a Western-type diet starting at 5 weeks of age for 12 weeks. Representative images of pinned Sudan-IV stained aortas from mice (en face analysis, Nceh1 genotype, and quantification values indicated). (B) Quantification of the surface area occupied by the lesions (% area occupied by the lesions, n = 10–11). The duration of the dietary load (12 weeks or 16 weeks) and Nceh1 genotype are indicated below the graphs in (B) and (D). (C) Representative photomicrographs of aortic root cross-sections stained with Oil-Red O. Nceh1 genotype is indicated above the images. (D) Quantification of the area occupied by lesions using cross-sections of aortic roots (n = 10–15). For analyzing the area occupied by atherosclerotic lesions, both the Mann-Whitney U test and two-tailed Student's t test were used. The P values generated by the two analyses were consistent. (E) Extraction of aortic wall lipids. After 12 weeks on a western-type diet, mice (n = 11–12 for males and n = 14–16 for females) were euthanized and the aortas were prepared. (F) Representative photomicrographs of F4/80-stained aortic root cross-sections from male mice fed a western-type diet for 12 weeks. (G) The quantification of the F4/80-stained area (n = 10 for each genotype). The macrophage lesion area is indicated as a percentage of the total lesion area. Data are expressed as the mean ± SEM. ∗ denotes p < 0.05 as determined with the two-tailed Student's t test for (E) and (G) (NS denotes nonsignificant difference). Cell Metabolism 2009 10, 219-228DOI: (10.1016/j.cmet.2009.08.004) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 4 nCEH Activity and Foam Cell Formation in Lipe−/−, Nceh1−/−, or Nceh1−/−;Lipe−/− Macrophages (A and B) Peritoneal macrophages (n = 6–7 for each genotype) were incubated with or without acLDL (100 μg/ml) for 24 hr, and nCEH (A) and TGL (B) activities were determined. (C) The nCEH activity after subcellular fractionation (n = 6–7). (D) Peritoneal macrophages (n = 8) were incubated with or without acLDL for 24 hr, and intracellular CE content and FC content were measured. (E) CE formation. Peritoneal macrophages (n = 7–8) were incubated with acLDL in the presence of [1-14C]oleate-albumin complex for 24 hr, and the incorporation of [1-14C]oleate into CE fraction was measured. Data are expressed as the mean ± SEM. ∗ and ∗∗ denote p < 0.05 and p < 0.01, respectively, as determined by ANOVA followed by the Tukey-Kramer posthoc test. Cell Metabolism 2009 10, 219-228DOI: (10.1016/j.cmet.2009.08.004) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 5 Cholesterol trafficking in Lipe−/−, Nceh1−/−, or Nceh1−/−;Lipe−/− Macrophages (A and B) Cholesterol efflux. Peritoneal macrophages (n = 6, A, n = 6–7, B) were incubated for 24 hr in DMEM containing 10% FCS (A) or 5% BSA (B) with acLDL (100 μg/ml) whose CE was reconstituted with cholesteryl[1,2-3H]linoleate. After labeling of the cells, the medium was changed to DMEM containing 10% FCS (A) or 5% BSA (B) with acLDL (100 μg/ml)in the presence or absence of HDL3 (250 μg/ml). (C) Peritoneal macrophages (n = 5–6) were incubated for 24 hr in DMEM containing 5% BSA with 100 μg/ml acLDL whose CE was reconstituted with cholesteryl[1,2-3H]linoleate. After labeling of the cells, the medium was changed to DMEM containing 5% BSA in the presence or absence of an ACAT inhibitor, CS-505 (10 μM) and/or HDL3 (250 μg/ml). After 24 hr, the radioactivity of an aliquot of the medium and cell lysate was measured. The percent efflux was calculated as (media dpm)/(cell + media dpm) × 100. (D) Microsomal ACAT activity. Peritoneal macrophages (n = 6–7) were incubated with or without acLDL (100 μg/ml) for 24 hr. ACAT activity in microsomes was determined by the rate of incorporation of [1-14C]oleoyl-CoA into the CE fraction. (E) Gene expression profile. Peritoneal macrophages (n = 4) were incubated with or without acLDL (100 μg/ml) for 24 hr. Nceh1, neutral cholesterol ester hydrolase 1; Lipe, hormone-sensitive lipase; Msr1, type A scavenger receptor; Scarb1, scavenger receptor class B type-I; Ldlr, the low-density lipoprotein receptor; Soat1, acyl-CoA:cholesterol acetyltransferase 1; Abca1, ATP-binding cassette transporter A1; Abcg1, ATP-binding cassette transporter G1. Loading was normalized by the expression of Rplp0 (acidic ribosomal phosphoprotein P0). (F) Cellular uptake and degradation of acLDL. Peritoneal macrophages (n = 5) were incubated with a medium containing varying concentrations of 125I-acLDL with or without a 40-fold excess of unlabeled acLDL for 5 hr at 37°C. The amounts of 125I-acLDL either degraded by or associated with the cells were measured. Data are expressed as the mean ± SEM. ∗ and ∗∗ denote p < 0.05 and p < 0.01, respectively, as determined by ANOVA (A−D) or repeated-measures ANOVA (F) followed by the Tukey-Kramer posthoc test. Cell Metabolism 2009 10, 219-228DOI: (10.1016/j.cmet.2009.08.004) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 6 Aherosclerosis in Ldlr−/− Mice with Nceh1−/−, Lipe−/−, or Nceh1−/−;Lipe−/− Bone Marrow (A)Irradiated female Ldlr−/− mice (age 8 weeks, n = 12–17) were transplanted with bone marrow cells isolated from male wild-type, Lipe−/−, Nceh1−/−, Nceh1−/−;Lipe−/− mice (age 8 weeks). Mice were maintained on a chow diet for the first 4 weeks, then switched to a high-cholesterol diet. After 12 weeks on the high-cholesterol diet, the mice were euthanized to assess their lesions. (A) shows verification of successful reconstitution with donor hematopoietic cells by PCR amplification of specific fragments of several genes. Genomic DNA from bone marrow of chimeric mice (the genotype of donor mice is indicated below) or tail was used as a template. The following templates were used as positive and negative controls (lane A and B): Tail DNA from a Nceh1+/+ and Nceh1−/− mouse for Nceh1 gene amplification, tail DNA from a Lipe+/+ and Lipe−/− mouse for Lipe gene amplification, tail DNA from a Ldlr+/+ and Ldlr−/− mouse for Ldlr gene amplification, and tail DNA from a female and male C57BL6/J mouse for Sry gene amplification in lane A and B, respectively. (B–E) Quantification by en face analysis (B) (quantification values indicated below the images) (C), and cross-sectional analysis (D and E). The genotypes of donor cells are indicated below the graphs. ∗ and ∗∗ denote p < 0.05 and p < 0.01, respectively, as determined by ANOVA followed by the Tukey-Kramer posthoc test. Cell Metabolism 2009 10, 219-228DOI: (10.1016/j.cmet.2009.08.004) Copyright © 2009 Elsevier Inc. Terms and Conditions